Navigation Links
Monitoring transfection efficiency by,,,green fluorescent protein (GFP) detection,,,with the Agilent 2100 bioanalyzer

This Application Note describes how the Agilent 2100 bioanalyzer and the Cell Fluorescence LabChip kit can be used to determine the efficiency of transfection of mammalian cells using green fluorescent protein (GFP) as a reporter molecule. Transfection of CHO-K1 cells with expression vectors encoding GFP from two different sources, and optimization of transfection conditions for both plasmids were performed. Histogram quality and the percent transfected cells determined, based on the low number of fluorescent cells counted with the microfluidic system, is in good agreement with data obtained with a conventional flow cytometer. Detailed protocols and reagent recommendations for analyzing transfection reactions are given. High reproducibility of chip results, low cell consumption and ease-of-use are advantages the compact Agilent 2100 bioanalyzer offers for monitoring transfection efficiency using GFP.
The Agilent 2100 bioanalyzer was introduced by Agilent Technologies as the first commercially available lab-on-a-chip analysis system for the life science laboratory using LabChipproducts, developed by Caliper Technologies Corp. Chip-based approaches for a variety of separation-based techniques have been introduced, addressing DNA, RNA, and protein separations. The Agilent 2100 bioanalyzer is capable of two-color fluorescence detection and runs disposable microfluidic glass chips. The application presented here is based on the controlled movement of cells through these channels by pressure-driven flow. Cells are hydrodynamically focused in the channels before passing the fluorescence detector in single file. Each chip accommodates several samples and data acquisition of all samples is fully automated while analysis allows for user-specific settings. Spec
'"/>

Source:


Page: All 1 2 3 4 5 6 7

Related biology technology :

1. Versatile Reporter Vectors for Monitoring Viral Transduction
2. Monitoring Microbial Populations Using Real-Time qPCR on the MJ Research Opticon 2 System
3. Monitoring Bacterial Genetic Diversity in a Freshwater Lake Using TTGE and DNA Sequence Analysis
4. Direct Monitoring of Solid-Phase Peptide Synthesis by MALDI-TOF MS
5. Monitoring fluorescence resonance energy transfer (FRET) between GFP fusions in lysates of the yeast Saccharomyces cerevisiae using the Varian Cary Eclipse
6. Monitoring Receptor-Mediated Changes in [Ca2+]i Using Single-Wavelength and Dual-Wavelength Indicators on the FlexStation Workstation
7. New statistical algorithms for Monitoring Gene Expression on GeneChip® Probe Arrays
8. Outstanding transfection rates using the Multiporator
9. Outstanding transfection rates using the Multiporator
10. Efficient DNA transfection of primary CNS neurons using TransMessenger Transfection Reagent
11. Confirming gene silencing mechanism by pGFP/GFP22 siRNA co-transfection

Post Your Comments:
(Date:11/24/2009)...tientswithadvanced-stage,orrecurrentendometrialcan.../-AEternaZentarisInc.(NASDAQ: AEZS ;TSX:AEZ)(the"C...ndocrinetherapyandoncology,todayannouncedpositivee...cpeptideconjugate,AEZS-108(formerlyAN-152),inpatie...sonalizedhealthcareapproach,thestudyselectedpatien...
(Date:11/24/2009)...irstCall/--GenomicHealth,Inc.(Nasdaq: GHDX )todaya...irman,willpresentatthe21stAnnualPiperJaffrayHealth...9at10:00a.m.ET. ,, Toaccesstheliveandsubsequent...rRelationssectionofGenomicHealth,swebsiteat http:/...siteatleast15minutespriortothebeginningofthepresen...
(Date:11/24/2009)...CellTherapeutics,Inc.(CTI)(NasdaqandMTA:CTIC)manag...areConference.TheconferencewillbeheldDecember1-2,2...nTuesday,December1at11:00a.m.EasternTimeinHolmes1(...beavailableat www.celltherapeutics.com ,anditwilla...yHealthCareConference,NewYorkPalaceHotel,Holmes1(4...
(Date:11/23/2009)...n layer in which the carbon atoms are arranged on ...n nanotubes are rolled-up sheets of graphene, and ...hene boasts some very special characteristics it ...conductor, and reconciles such conflicting qualiti...hene is impermeable to gases, which makes it inter...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2Polymer with honeycomb structure 2
...Medicine, LLC (SM),a wholly-owned subsidiary of Ce...), today announced they have entered into a Cooper...ith the National Cancer Institute (NCI),of the Nat... CRADA is to,develop patented products for the tre...man monoclonal antibodies (hmAbs), peptides, and s...
... Zyvex Labs today announced,its first company spi... Rob,Burgess, PhD, former Vice President of Resear...Hughes, PhD, former Group Leader of Life Sciences,...pplication of nanotechnology in Life,Sciences. The...for the,development of research grade reagents and...
...21 ChemAxon, a software,solutions provider for ch...f Instant JChem, it,s desktop application for work...te databases. The version 2 release brings,forms a...d query building,and multi-user access. Instant JC... functionality and is free for all users. Instant...
Other Biology Technology:Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway 2Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway 3Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway 4Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway 5NanoMed, Inc. Spins Out of Zyvex Labs 2Instant JChem 2.0 Released: Instant JChem Personal Free for All Users 2
(Date:11/24/2009)...NEW YORK (November 24, 2009) -- The Wildlife Conse...ealing that the last remaining population of Siber...o the rising tide of poaching and habitat loss. ,... Russian officials of what needs to be done to pro...cat. , The report was released by t...
(Date:11/23/2009)...search presents strong evidence that the "synergis... traffic-related pollution and indoor endotoxin ca... other exposure alone. , Environmental health ...llege of Medicine have shown that children exposed...and indoor endotoxin during early life are six tim...
(Date:11/23/2009)...- More than 160 participants gathered this week fo...ES INITIATIVE conference. This year,s topic, "Synt...eers, and medical researchers to explore the engin...the emerging field of synthetic biology. , Bonni...inceton University and this year,s conference chai...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Coverall Honored as Finalist in Six Categories for 2009 Stevie Awards 56139 1Coverall Honored as Finalist in Six Categories for 2009 Stevie Awards 56139 2Coverall Honored as Finalist in Six Categories for 2009 Stevie Awards 56139 3Oramed Pharmaceuticals to Present at Rodman 26 Renshaw 11th Annual Healthcare Conference 13832 1Oramed Pharmaceuticals to Present at Rodman 26 Renshaw 11th Annual Healthcare Conference 13832 2Rochester Medical Launches StrataSI 28TM 29 26 StrataNF 28TM 29 Next Generation Foley Catheters 56132 1Rochester Medical Launches StrataSI 28TM 29 26 StrataNF 28TM 29 Next Generation Foley Catheters 56132 2Rochester Medical Launches StrataSI 28TM 29 26 StrataNF 28TM 29 Next Generation Foley Catheters 56132 3
... amounts of a small protein called TCTP (translati...e cells of fruit flies, they are smaller than norm... in the growth and proliferation of cells, said re...t in current issue of the journal Nature. , Work ...regulating Rheb (Ras homologue enriched in brain),...
...bumblebees always aren,t as busy as, well, a bee. ...s have known that a key to the insects, success in...aintain fairly stable body temperatures when flyin...t temperature was poorly understood. But now scie...niversity of Puget Sound have peered into bumblebe...
... the help of a new type of suture based on MIT res... have them removed. , A biopolymer suture cleared ...e human body produces naturally, so they can be sa...lso 30 percent stronger than sutures now used and ...work with. , The sutures were developed by Teph...
Other Biology News:Bumblebee house warming -- it takes a village 2Bumblebee house warming -- it takes a village 3Natural polyester makes new sutures stronger, safer 2
5X StabilCoat Immunoassay Stabilizer from SurModics, Inc.
Mouse Anti-Human PARK2 Monoclonal Antibody, Unconjugated, Clone 1H4 from Novus Biologicals
Pokeweed Mitogen Spleen Cell Conditioned Medium, 25 mL from StemCell Technologies, Inc.
Mouse Anti-Human FMN2 Monoclonal Antibody, Unconjugated, Clone 4B8 from Novus Biologicals
Biology Products: